Metabolic profiling of livers and blood from obese Zucker rats

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 42, Issue 6, Pages (June 2005)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 44, Issue 6, Pages (June 2006)
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Volume 42, Issue 4, Pages (April 2005)
Reply to: “DCD consensus and futility in liver transplantation”
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility  Quentin M. Anstee, Christopher P. Day  Journal.
Hepatitis C core protein – The “core” of immune deception?
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 59, Issue 3, Pages (September 2013)
Volume 62, Issue 3, Pages (March 2015)
Volume 44, Issue 1, Pages (January 2006)
Volume 44, Issue 3, Pages (March 2006)
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 41, Issue 4, Pages (October 2004)
Volume 57, Issue 5, Pages (November 2012)
Hepatology may have problems with putative surrogate outcome measures
Volume 50, Issue 4, Pages (April 2009)
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 42, Issue 6, Pages (June 2005)
Volume 56, Issue 6, Pages (June 2012)
Chetana Lim, Chady Salloum, Daniel Azoulay
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Volume 64, Issue 6, Pages (June 2016)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass,
Volume 44, Issue 1, Pages (January 2006)
Volume 50, Issue 1, Pages 4-6 (January 2009)
The relationship between age and fat infiltration in liver and muscle
Volume 44, Issue 4, Pages (April 2006)
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Metabolic profiling of livers and blood from obese Zucker rats Natalie J. Serkova, Matthew Jackman, Jaimi L. Brown, Tao Liu, Ryutaro Hirose, John P. Roberts, Jacquelyn J. Maher, Claus U. Niemann  Journal of Hepatology  Volume 44, Issue 5, Pages 956-962 (May 2006) DOI: 10.1016/j.jhep.2005.07.009 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 (A) and (B): Representative histology from a lean Zucker rat at magnification 100× (A) and magnification 200× (B). Liver parenchyma shows normal structure. (C) and (D): Representative histology from an obese Zucker rat at magnification 100× (C) and magnification 200× (D). Slide A: no significant fatty changes are present. Slide C: rare hepatocytes show large droplet fat. Significant steatotic changes (>30% fatty infiltration) were not present on either slide. [This figure appears in colour on the web.] Journal of Hepatology 2006 44, 956-962DOI: (10.1016/j.jhep.2005.07.009) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Representative 1H-NMR spectra from water-soluble acid extracts of livers from lean (A) and obese (B) Zucker rats. 1, glutamate; 2, glutamine; 3, glutathione; Ala, alanine; OH-But, hydroxybutyrate; Glc, glucose; Glyc, glycogen; Lac, lactate; Suc, succinate; Val, valine+leucine+isoleucine. Journal of Hepatology 2006 44, 956-962DOI: (10.1016/j.jhep.2005.07.009) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Methionine metabolism in the liver. 1, methionine adenosyltransferase; 2, vitamin B6; DMG, dimethylglycine; GSH, glutathione; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine. [This figure appears in colour on the web.] Journal of Hepatology 2006 44, 956-962DOI: (10.1016/j.jhep.2005.07.009) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions